Raleigh, N.C. — International drug giant Novartis (NYSE: NVS), which is building a vaccine plant in Holly Springs, has made a $625,000 gift to the College of Veterinary Medicine at N.C. State.
The funds will be used for the clinical trials program at the school’s Center for Comparative Medicine and Translational Research.
NCSU will use the funds for a clinical trials veterinarian, a research technician, lab space and equipment. The grant will be spread over five years.
“Clinical studies are integral to the advancement of veterinary medicine,” said Gregg Dean, director of the Center for Comparative Medicine and Translational Research. “Such studies investigate risk factors for disease as well as methods to prevent, treat or cure illnesses that affect both animals and humans. The Novartis gift will fund resources that are critical to helping the CCMTR ensure an effective Clinical Trials Program.”
NCSU veterinary school receives $625,000 gift from Novartis for clinical trials
Copyright 2008 by WRAL.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
- Inspire Pharmaceuticals launches clinical trial for glaucoma treatment
Oct. 10, 2008 - Veteran life science exec to chair PhaseBio board
Oct. 10, 2008 - FDA decision means delay in $25M payment to PPD
Oct. 10, 2008 - Charlotte Biotechnology Conference to feature N.C. Research Campus
Oct. 10, 2008 - RIP, good times – Venture giant Sequoia warns execs on how to survive coming recession
Oct. 10, 2008
- Inspire Pharmaceuticals launches clinical trial for glaucoma treatment
-
- Who needs ‘crowdsourcing'? Innovation needs experts
Oct. 10, 2008 - S.C. startup MedProcure lands $150K investment
Oct. 10, 2008 - Apple to unveil new products (notebooks?) on October 14
Oct. 9, 2008 - Georgia-based Integrated Broadband Services acquires Canadian firm
Oct. 9, 2008 - Atlanta-based Multicast names CFO who had been CEO of firm acquired by ChannelAdvisor
Oct. 9, 2008
- Who needs ‘crowdsourcing'? Innovation needs experts
More from wrallocaltechwire.com
Market Watch

